
Transcriptome-based identification of lovastatin as a breast cancer stem cell-targeting drug.

Transcriptome-based identification of lovastatin as a breast cancer stem cell-targeting drug.
Quality attributes of partially hydrolyzed collagen in a liquid formulation used for skin care. VER MÁS
The dialyzable leukocyte extract TransferonTM inhibits tumor growth and brain metastasis in a murine model of prostate cancer. VER...
An international comparative analysis and roadmap to sustainable biosimilar markets. VER MÁS
Fecha de publicación: 20 de marzo del 2021 Consistency of a dialyzable leucocyte extract manufactured at GMPfacilities by Nuclear...
Regulatory Pathway for Licensing Biotherapeutics in Mexico. VER MÁS
Progress and Challenges in the Design and Clinical Development of Antibodies for Cancer Therapy. VER MÁS
Fecha de publicación: 27 de febrero de 2023 Discovery and Optimization of Neutralizing SARS-CoV-2 Antibodies Using ALTHEA Gold Plus...
Sequencing Analysis and Identification of the Primary Peptide Component of the Dialyzable Leukocyte Extract “Transferon Oral”: The Starting Point...

+52 (55) 5729 6000 Ext. 62543
Escuela Nacional de Ciencias Biológicas. Prolongación de Carpio y Plan de Ayala S/N, Del. Miguel Hidalgo, CDMX, C.P. 11340.
©2026 UDIBI